VICORE PHARMA HOLDING AB

VICORE PHARMA HOLDING AB

Share · SE0007577895 · A14W4W (XSTO)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of VICORE PHARMA HOLDING AB
No Price
Closing Price XSTO 29.04.2026: 10,02 SEK
29.04.2026 14:46
Current Prices from VICORE PHARMA HOLDING AB
ExchangeTickerCurrencyLast TradePriceDaily Change
XSTO: NASDAQ STOCKHOLM AB
NASDAQ STOCKHOLM AB
VICO.ST
SEK
29.04.2026 14:46
10,02 SEK
0,00 SEK
XHAM: Hamburg
Hamburg
VPHABN95.HAMB
EUR
29.04.2026 06:11
0,93 EUR
-0,06 EUR
-6,28 %
XDQU: Quotrix
Quotrix
VPHABN95.DUSD
EUR
29.04.2026 05:27
0,92 EUR
-0,06 EUR
-6,48 %
XDUS: Düsseldorf
Düsseldorf
VPHABN95.DUSB
EUR
28.04.2026 17:32
0,91 EUR
-0,08 EUR
-7,80 %
Share Float & Liquidity
Free Float 76,31 %
Shares Float 182,05 M
Shares Outstanding 238,56 M
Company Profile for VICORE PHARMA HOLDING AB Share
Vicore Pharma Holding AB (publ) engages in the research and development of pharmaceutical products for the treatments for rare lung diseases. The company is developing VP01, a small molecule compound for oral administration that is in phase II clinical trial for the treatment of interstitial lung diseases, idiopathic pulmonary fibrosis (IPF), systemic sclerosis, and COVID-19; and VP02, a formulation and delivery route for an existing immunomodulatory compound, which is preclinical trials to treat patients with IPF. It has a cooperation and development agreement with Emeriti Bio AB; license agreement with Nanologica AB (publ); and a collaboration agreement with Alex Therapeutics AB for the development and clinical validation of a digital therapeutic (DTx) built on the Alex DTx platform. The company was formerly known as Mintage Scientific AB. Vicore Pharma Holding AB (publ) was founded in 2000 and is headquartered in Gothenburg, Sweden.

Company Data

Name VICORE PHARMA HOLDING AB
Company Vicore Pharma Holding AB (publ)
Website https://www.vicorepharma.com
Primary Exchange XSTO NASDAQ STOCKHOLM AB
WKN A14W4W
ISIN SE0007577895
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Ahmed S. Mousa
Market Capitalization 2 Mrd.
Country Sweden
Currency SEK
Employees 0,0 T
Address Kronhusgatan 11, 411 05 Stockholm
IPO Date 2015-12-10

Stock Splits

Date Split
14.09.2018 1141:1000

Ticker Symbols

Name Symbol
NASDAQ STOCKHOLM AB VICO.ST
Düsseldorf VPHABN95.DUSB
Frankfurt 6Y4.F
Hamburg VPHABN95.HAMB
Quotrix VPHABN95.DUSD
More Shares
Investors who hold VICORE PHARMA HOLDING AB also have the following shares in their portfolio:
Hubei Zhongyi Science Technology Co., Ltd.
Hubei Zhongyi Science Technology Co., Ltd. Share
Schwab U.S. Aggregate Bond Index Fund
Schwab U.S. Aggregate Bond Index Fund Fund